Euretina Logo, Links to homepage.
Euretina Logo, Links to homepage.

Evaluation of a calculation model to estimate the impact of the COVID-19 pandemic lockdown on visual acuity in neovascular AMD

Author: Martin Stattin (Austria)

Co-authors: Anna-Maria Haas, Daniel Ahmed, Alexandra Graf, Katharina Krepler, Siamak Ansari-Shahrezaei

Purpose

To evaluate a calculation model performed during the Austrian coronavirus disease 2019 (COVID-19) pandemic lockdown to estimate the effect of short-term treatment interruption due to health care restrictions on visual acuity (VA) in exudative neovascular age-related macular degeneration (nAMD).

Setting/Venue

Retrospective data collection of 142 eyes in 142 patients receiving repeated intravitreal injections with anti-vascular endothelial growth factor at the Medical Retina Unit service (Rudolf Foundation Hospital, Vienna) in a personalized pro re nata regimen prior to the COVID-19 associated lockdown, when treatment was deferred between March 16 and May 4, 2020.

Methods

During the lockdown, the preliminary data was integrated into pre-existing formulae based on the natural course of the disease in the long term. Patients were re-scheduled and treated after gradually opening operating rooms. The calculation model was compared to the effective VA change.

Results

The model calculated an overall VA loss of 3.5±0.8 letters early treatment diabetes retinopathy study (ETDRS) (p<0.001 [95% CI:3.3;3.6]) on average compared to 2.5±6 letters ETDRS (p<0.001 [95% CI:1.5;3.5]) as measured after re-opening the doors with a mean treatment delay of 61±14 days. The total difference between the model exercise and the real-life outcomes accounted for 1±5.9 letters ETDRS (p=0.051 [95% CI:0;2]).

Conlusions

The herein presented calculation model might not be suitable to estimate the effective VA loss correctly. Untreated eyes and eyes under previous therapy behave differently after short-term treatment interruption. However, this study demonstrated the potentially negative impact of the COVID-19 pandemic lockdown on patients compromised by nAMD.

Financial Disclosure

No financial disclosure

Comments

-

IMPORTANT INFORMATION

Beware of fraudulent websites, emails and hotel booking offers

www.euretina.org is the only official website of the European Society of Retina Specialists.
 
Please be wary of websites, emails from third-party agencies using similar names, addresses or branding and purporting to represent Euretina.
 
This includes websites or companies offering Congress registration, hotel accommodation or travel services while claiming to be affiliated with Euretina.

Should you use any website other than www.euretina.org, or book accommodation through an unauthorised third-party site, you may be charged significantly more than the official registration fee, your hotel booking may not be valid, and you may not be registered for the event at all.
 
If you have any questions in relation to registration or accommodation for the Congress, these should only be directed to [email protected].